SAMSUNG PHARM. Co., LTD. (KRX:001360)
South Korea · Delayed Price · Currency is KRW 1,714.00
-54.00 (-3.05%)
May 15, 2026, 11:00 AM KST
SAMSUNG PHARM. Co., LTD. Market Cap
SAMSUNG PHARM. Co., LTD. has a market cap or net worth of 166.59 billion as of May 14, 2026. Its market cap has increased by 17.69% in one year.
Market Cap
166.59B
Enterprise Value
n/a
Revenue
44.29B
Ranking
n/a
PE Ratio
13.11
Stock Price
1,714.00
Market Cap Chart
Since August 31, 1995, SAMSUNG PHARM. Co., LTD.'s market cap has increased from 17.88B to 166.59B, an increase of 831.48%. That is a compound annual growth rate of 7.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 13, 2026 | 166.59B | 15.69% |
| Dec 30, 2025 | 144.00B | -0.52% |
| Dec 30, 2024 | 144.76B | -0.84% |
| Dec 28, 2023 | 145.99B | -18.99% |
| Dec 29, 2022 | 180.22B | -45.48% |
| Dec 30, 2021 | 330.57B | -11.17% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AptaBio Therapeutics | 206.49B |
| Whan In Pharm | 203.32B |
| JW Lifescience | 195.11B |
| Jeil Pharmaceutical Co.,Ltd | 191.91B |
| Samil Pharmaceutical Co.,Ltd | 186.40B |
| Ilyang Pharmaceutical Co.,Ltd | 179.25B |
| Hana Pharm | 171.51B |
| Daihan Pharmaceutical | 165.52B |